Author:
Rubin Michael,Mokyr Margalit B.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference23 articles.
1. Bartik MM, Ahn M-C, Baumgartel BA, Hendricks RL, Mokyr MB (1990) Presence of an enlarged pool of MOPC-315-specific cytotoxic T-lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy. Cancer Immunol Immunother 32: 143
2. Bartik MM, Baumgartel-Scofield BA, Mokyr MB (1991) Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers. Cancer Immunol Immunother 34: 79
3. Ben-Efraim S, Bocian RC, Mokyr MB, Dray S (1983) Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth. Cancer Immunol Immunother 15: 101
4. Berko R, Seissman K, Colvin M, Bocian RC, Ben-Efraim S, Dray S (1988) Tumoricidal and immunomodulatory activities of drugs and implications for therapy of mice bearing a late stage MOPC-315 plasmacytoma. Int J Immunopharmacol 10: 825
5. Berd D, Maguire HC, Mastrangelo MJ (1985) Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with melanoma cell vaccine preceded by cyclophosphamide. Cancer Res 46: 2572
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献